idecabtagene vicleucel
bms,2seventy bio
['karmma', 'mmsm']
my reaction after i was asked if we can give car-t in early relapse myeloma based on karmma-3 results! while we have a long waiting list for late relapse!! #mmsm #medtwitter #ash22 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter